Objective: Report manganese serum levels and mortality in encephalopathic patients. Patients and participants: Consecutive patients aged \> 18 years, with hepatic encephalopathy and informed consent signed by their families. Interventions: Patients' clinical characteristics as well as biochemical tests of renal function, hemoglobin, glucose and albumin levels were obtained as well as a blood sample to analyze manganese levels with a graphite furnace atomic absorption spectrometer. Hypothesis: There is a difference in the manganese levels between male and female patients.
Study Type
OBSERVATIONAL
Enrollment
9
General Hospital "Dr. Darío Fernández Fierro"
México, D.f., Mexico
Clinical Evolution
Number of participants who died versus those who remained alive after 6 months of follow up since the first entrance at the Emergency Room
Time frame: six months
Manganese Levels
From encephalopathic patients, we took individual blood samples, analyzed in the biochemistry laboratory at the National Institute of Neurology and Neurosurgery, Mexico, City, with a graphite furnace atomic absorption spectrometer, according to the technique reported by Pleban.
Time frame: Up to six months we followed the recruited patients to determine who were still alive
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.